180 related articles for article (PubMed ID: 26827990)
1. Amygdalin delays cell cycle progression and blocks growth of prostate cancer cells in vitro.
Makarević J; Tsaur I; Juengel E; Borgmann H; Nelson K; Thomas C; Bartsch G; Haferkamp A; Blaheta RA
Life Sci; 2016 Feb; 147():137-42. PubMed ID: 26827990
[TBL] [Abstract][Full Text] [Related]
2. Amygdalin inhibits the growth of renal cell carcinoma cells in vitro.
Juengel E; Thomas A; Rutz J; Makarevic J; Tsaur I; Nelson K; Haferkamp A; Blaheta RA
Int J Mol Med; 2016 Feb; 37(2):526-32. PubMed ID: 26709398
[TBL] [Abstract][Full Text] [Related]
3. Pao Pereira Extract Suppresses Castration-Resistant Prostate Cancer Cell Growth, Survival, and Invasion Through Inhibition of NFκB Signaling.
Chang C; Zhao W; Xie B; Deng Y; Han T; Cui Y; Dai Y; Zhang Z; Gao J; Guo H; Yan J
Integr Cancer Ther; 2014 May; 13(3):249-58. PubMed ID: 24287876
[TBL] [Abstract][Full Text] [Related]
4. KLF9, a transcription factor induced in flutamide-caused cell apoptosis, inhibits AKT activation and suppresses tumor growth of prostate cancer cells.
Shen P; Sun J; Xu G; Zhang L; Yang Z; Xia S; Wang Y; Liu Y; Shi G
Prostate; 2014 Jun; 74(9):946-58. PubMed ID: 24737412
[TBL] [Abstract][Full Text] [Related]
5. Suppression of human prostate cancer cell growth by ciprofloxacin is associated with cell cycle arrest and apoptosis.
Aranha O; Grignon R; Fernandes N; McDonnell TJ; Wood DP; Sarkar FH
Int J Oncol; 2003 Apr; 22(4):787-94. PubMed ID: 12632069
[TBL] [Abstract][Full Text] [Related]
6. Antiproliferative effect of 1alpha,25-dihydroxyvitamin D3 in human prostate cancer cell line LNCaP involves reduction of cyclin-dependent kinase 2 activity and persistent G1 accumulation.
Zhuang SH; Burnstein KL
Endocrinology; 1998 Mar; 139(3):1197-207. PubMed ID: 9492054
[TBL] [Abstract][Full Text] [Related]
7. Dryopteris crassirhizoma has anti-cancer effects through both extrinsic and intrinsic apoptotic pathways and G0/G1 phase arrest in human prostate cancer cells.
Chang SH; Bae JH; Hong DP; Choi KD; Kim SC; Her E; Kim SH; Kang CD
J Ethnopharmacol; 2010 Jul; 130(2):248-54. PubMed ID: 20438825
[TBL] [Abstract][Full Text] [Related]
8. Amygdalin Exerts Antitumor Activity in Taxane-Resistant Prostate Cancer Cells.
Tsaur I; Thomas A; Monecke M; Zugelder M; Rutz J; Grein T; Maxeiner S; Xie H; Chun FK; Rothweiler F; Cinatl J; Michaelis M; Haferkamp A; Blaheta RA
Cancers (Basel); 2022 Jun; 14(13):. PubMed ID: 35804883
[TBL] [Abstract][Full Text] [Related]
9. Amygdalin blocks bladder cancer cell growth in vitro by diminishing cyclin A and cdk2.
Makarević J; Rutz J; Juengel E; Kaulfuss S; Reiter M; Tsaur I; Bartsch G; Haferkamp A; Blaheta RA
PLoS One; 2014; 9(8):e105590. PubMed ID: 25136960
[TBL] [Abstract][Full Text] [Related]
10. Mechanisms of natural brassinosteroid-induced apoptosis of prostate cancer cells.
Steigerová J; Rárová L; Oklešt'ková J; Křížová K; Levková M; Sváchová M; Kolář Z; Strnad M
Food Chem Toxicol; 2012 Nov; 50(11):4068-76. PubMed ID: 22939933
[TBL] [Abstract][Full Text] [Related]
11. Effects of INPP4B gene transfection combined with PARP inhibitor on castration therapy-resistant prostate cancer cell line, PC3.
Ding H; Sun Y; Hou Y; Li L
Urol Oncol; 2014 Jul; 32(5):720-6. PubMed ID: 24837011
[TBL] [Abstract][Full Text] [Related]
12. Induced apoptosis in human prostate cancer cell line LNCaP by Ukrain.
Roublevskaia IN; Haake AR; Ludlow JW; Polevoda BV
Drugs Exp Clin Res; 2000; 26(5-6):141-7. PubMed ID: 11345020
[TBL] [Abstract][Full Text] [Related]
13. Mechanisms involved in resveratrol-induced apoptosis and cell cycle arrest in prostate cancer-derived cell lines.
Benitez DA; Pozo-Guisado E; Alvarez-Barrientos A; Fernandez-Salguero PM; Castellón EA
J Androl; 2007; 28(2):282-93. PubMed ID: 17050787
[TBL] [Abstract][Full Text] [Related]
14. Amygdalin Modulates Prostate Cancer Cell Adhesion and Migration In Vitro.
Mani J; Neuschäfer J; Resch C; Rutz J; Maxeiner S; Roos F; Chun FK; Juengel E; Blaheta RA
Nutr Cancer; 2020; 72(3):528-537. PubMed ID: 31298931
[TBL] [Abstract][Full Text] [Related]
15. Jungermannenone A and B induce ROS- and cell cycle-dependent apoptosis in prostate cancer cells in vitro.
Guo YX; Lin ZM; Wang MJ; Dong YW; Niu HM; Young CY; Lou HX; Yuan HQ
Acta Pharmacol Sin; 2016 Jun; 37(6):814-24. PubMed ID: 27133304
[TBL] [Abstract][Full Text] [Related]
16. A concentrated aglycone isoflavone preparation (GCP) that demonstrates potent anti-prostate cancer activity in vitro and in vivo.
Bemis DL; Capodice JL; Desai M; Buttyan R; Katz AE
Clin Cancer Res; 2004 Aug; 10(15):5282-92. PubMed ID: 15297432
[TBL] [Abstract][Full Text] [Related]
17. SRJ23, a new semisynthetic andrographolide derivative: in vitro growth inhibition and mechanisms of cell cycle arrest and apoptosis in prostate cancer cells.
Wong HC; Wong CC; Sagineedu SR; Loke SC; Lajis NH; Stanslas J
Cell Biol Toxicol; 2014 Oct; 30(5):269-88. PubMed ID: 25070834
[TBL] [Abstract][Full Text] [Related]
18. Tanshinone IIA inhibits human prostate cancer cells growth by induction of endoplasmic reticulum stress in vitro and in vivo.
Chiu SC; Huang SY; Chen SP; Su CC; Chiu TL; Pang CY
Prostate Cancer Prostatic Dis; 2013 Dec; 16(4):315-22. PubMed ID: 24042854
[TBL] [Abstract][Full Text] [Related]
19. A novel anticancer agent, icaritin, induced cell growth inhibition, G1 arrest and mitochondrial transmembrane potential drop in human prostate carcinoma PC-3 cells.
Huang X; Zhu D; Lou Y
Eur J Pharmacol; 2007 Jun; 564(1-3):26-36. PubMed ID: 17382317
[TBL] [Abstract][Full Text] [Related]
20. The effect of chelerythrine on cell growth, apoptosis, and cell cycle in human normal and cancer cells in comparison with sanguinarine.
Malíková J; Zdarilová A; Hlobilková A; Ulrichová J
Cell Biol Toxicol; 2006 Nov; 22(6):439-53. PubMed ID: 16964588
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
